N. B. Iannucci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
N. B. Iannucci has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
O. Cascone
Department of Biological Chemistry and Institute of Biochemistry and Biophysics (IQUIFIB), School of Pharmacy and Biochemistry; University of Buenos Aires; Junín 956, C1113AAD Buenos Aires, Argentina
2 shared publicationsA.A.N. Cañizo
Facultad de Farmacia y Bioquímica, Argentina
1 shared publicationF.J. Wolman
Facultad de Farmacia y Bioquímica, Argentina
1 shared publication- Fernando Albericio
Peptide Science Laboratory, School of Chemistry and Physics University of KwaZulu‐Natal Durban South Africa
1 shared publication - José María Delfino
IQUIFIB (UBA-CONICET) and Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina
1 shared publication L. M. Curto
Department of Biological Chemistry and Institute of Biochemistry and Biophysics (IQUIFIB), School of Pharmacy and Biochemistry; University of Buenos Aires; Junín 956, C1113AAD Buenos Aires, Argentina
1 shared publication
Latest Publications
- 27 August 2013
- Published by Wiley in Biopolymers
- Vol. 102 (1) , 49-57
Structural glance into a novel anti-staphylococcal peptide
Novel antimicrobial peptides are valuable molecules for developing anti-infective drugs to counteract the contemporary spread of microbial drug-resistance. Here we focus on a novel peptide (RKWVWWRNR-NH2) derived from the fragment 107–115 of the human lysozyme that displays a 20-fold increase in anti-staphylococcal activity. The conformational analysis of this peptide and its interaction with model lipidic phases—as assayed by circular dichroism and fluorescence spectroscopy—show a noteworthy spectral change, which might be related to its anti-staphylococcal activity. The secondary structure of peptide [K108W111] 107–115 hLz was dramatically affected through a single substitution at position 111 (Ala by Trp). Therefore, this conformational change might improve the interaction of the novel peptide with the bacterial plasma membrane. These results highlight the role of peptide secondary structure and the distribution of polar/nonpolar residues for the effective interaction of this peptide with the bacterial plasma membrane, a key step for triggering its lethal effect. This knowledge may contribute to the rational design of a new generation of antimicrobial peptides with increased efficacy developed from natural sources by simple screening tools. © 2013 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 49–57, 2014.
- 27 August 2013
- Published by Wiley in Biopolymers
- Vol. 102 (1) , 49-57
Structural glance into a novel anti-staphylococcal peptide
Novel antimicrobial peptides are valuable molecules for developing anti-infective drugs to counteract the contemporary spread of microbial drug-resistance. Here we focus on a novel peptide (RKWVWWRNR-NH2) derived from the fragment 107–115 of the human lysozyme that displays a 20-fold increase in anti-staphylococcal activity. The conformational analysis of this peptide and its interaction with model lipidic phases—as assayed by circular dichroism and fluorescence spectroscopy—show a noteworthy spectral change, which might be related to its anti-staphylococcal activity. The secondary structure of peptide [K108W111] 107–115 hLz was dramatically affected through a single substitution at position 111 (Ala by Trp). Therefore, this conformational change might improve the interaction of the novel peptide with the bacterial plasma membrane. These results highlight the role of peptide secondary structure and the distribution of polar/nonpolar residues for the effective interaction of this peptide with the bacterial plasma membrane, a key step for triggering its lethal effect. This knowledge may contribute to the rational design of a new generation of antimicrobial peptides with increased efficacy developed from natural sources by simple screening tools. © 2013 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 49–57, 2014.
- Open Access
- 1 March 2003
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Chemical Engineering
- Vol. 20 (1) , 27-32
Affinity chromatography with pseudobiospecific ligands on high-performance supports for purification of proteins of biotechnological interest
High-performance affinity matrices were obtained by attaching pseudobiospecific ligands to hollow-fibre membranes. The neutral protease contained in FlavourzymeTM was purified to homogeneity with Yellow 4R-HE affinity hollow-fibre membranes. Immobilisation of Red HE-3B allowed purification of a milk-clotting enzyme obtained by solid-state culture of Mucor bacilliformis. Copper immobilisation through iminodiacetic acid allowed fractionation of Biocon Bioconcentrated PlusTM to separate the pectinesterase-containing fraction. The productivity of the developed processes - 1900, 94 and 750 U/ml.min, respectively - was 10- to 15-fold higher than that achieved with the same ligands immobilised on agarose-based soft gels, mainly due to the shortening of the purification processes
- 1 March 2003
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Chemical Engineering
- Vol. 20 (1) , 27-32
Open AccessAffinity chromatography with pseudobiospecific ligands on high-performance supports for purification of proteins of biotechnological interest
High-performance affinity matrices were obtained by attaching pseudobiospecific ligands to hollow-fibre membranes. The neutral protease contained in FlavourzymeTM was purified to homogeneity with Yellow 4R-HE affinity hollow-fibre membranes. Immobilisation of Red HE-3B allowed purification of a milk-clotting enzyme obtained by solid-state culture of Mucor bacilliformis. Copper immobilisation through iminodiacetic acid allowed fractionation of Biocon Bioconcentrated PlusTM to separate the pectinesterase-containing fraction. The productivity of the developed processes - 1900, 94 and 750 U/ml.min, respectively - was 10- to 15-fold higher than that achieved with the same ligands immobilised on agarose-based soft gels, mainly due to the shortening of the purification processes